Dr.’s Nikhil Shah & Hiep Nguyen, Co-Founders, Nephrodite Inc.
A line exists today. On one side is a vinyl chair beneath cold fluorescent lights. A dialysis machine whirs. The patient sits, scratching their access site, wondering how many thousands of hours they’ll languish in that chair and reflecting on all they’ve sacrificed: jobs, family, travel…..life.
They are now the fourth generation to rely on, at great personal cost, life-saving technology from the 1950s, center-based kidney dialysis.
On the other side of that line is Nephrodite. Our team of physicians, scientists and biomedical engineers are working tirelessly to ensure this generation is the last to sacrifice so much quality of life, to sustain life.
We’re proving that the future of kidney care begins now:
- Our artificial implantable kidney replacement technology platform, Holly™ by Nephrodite, has achieved continuous, successful operation in a living organism for multiple days in awake conditions, the longest validated performance of any implantable artificial kidney to date.
- We have received the FDA’s Breakthrough Device designation, unlocking an expedited pathway for approval.
- Further, we are moving fast towards first-in-human trials, demonstrating both our readiness and the strong momentum behind Nephrodite’s development.
In the United States alone, billions of dollars are spent each year to treat just one million patients, an extraordinary cost for a system designed to sustain life rather than restore it. We have designed the Holly™ by Nephrodite platform to not just to reduce costs, but to provide what money can’t buy: a future free from countless hours in the dialysis chair, empowering patients to reclaim their independence.
Nephrodite exists not just to improve kidney care, but to transform it. We invite you to step across the line with us.